FDA Approves Juvmo, a Once-Daily Pill for Parkinson’s Born of Decades-Long D1 Receptor Research
The FDA has approved tavapadon, branded Juvmo, a once-daily D1 dopamine receptor agonist for Parkinson's disease developed from more than ...
Tag: D1 dopamine receptor agonist
POPULAR NEWS
-
Alloys That Shrink Their Own Grains: New PIX Mechanism Refines Metals With Heat Alone
-
Endurance Exercise Reshapes the Liver in Males and Females Through Distinct Molecular Routes
-
Single Transcription Factor PU.1 Rapidly Converts Fibroblasts into Macrophage-Lineage Cells
-
New Scale Measures How Ready Nurse Educators Really Are for the AI Era